ArticleBMC pharmacology & toxicology2026
Novel mechanisms of atrazine endocrine disruption: an integrated approach reveals progesterone and glucocorticoid receptor targeting.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAtrazine is a widely used herbicide with reported endocrine-disrupting effects, yet the molecular targets and pathway-level mechanisms remain to be fully elucidated. We aimed to build an integrated, hypothesis-generating workflow to prioritize candidate atrazine targets by combining literature curation, network analysis, machine-learning–based prioritization, and molecular docking.
methodsCandidate endocrine-related genes were compiled from the Comparative Toxicogenomics Database and PubMed literature screening, yielding 78 genes. A protein–protein interaction (PPI) network was constructed and analyzed to identify a connected subnetwork of 26 genes. Gene Ontology (GO) and KEGG enrichment analyses were performed to characterize overrepresented biological processes and pathways. To prioritize candidate genes within the 26-gene subnetwork, we engineered composite network features and trained a weakly supervised model using three literature-labeled seed positives (ESR1, CYP19A1, and AR) versus the remaining genes as putative negatives, with internal cross-validation for exploratory assessment. Molecular docking was conducted for selected receptors to evaluate potential binding signals.
resultsNetwork topology and enrichment analyses highlighted endocrine-related and steroid hormone–associated biological functions within the atrazine-associated gene set. In exploratory internal cross-validation on the 26-gene subnetwork, an ensemble model showed high apparent discrimination. The prioritization step ranked NR3C1 and PGR among the top candidates for follow-up. Docking simulations suggested moderate binding affinities between atrazine and PGR (− 6.495 kcal/mol) and NR3C1 (− 6.248 kcal/mol), providing complementary in silico evidence consistent with these candidates and motivating investigation of progesterone- and glucocorticoid-related signaling.
conclusionsThis integrative in silico workflow supports a network-informed prioritization of potential atrazine endocrine targets and highlights NR3C1 and PGR as candidates warranting further investigation. Because the machine-learning component is trained on a very limited literature-labeled set and no external test set is available, the findings should be interpreted as hypothesis-generating and require validation in biological models (in vitro and/or in vivo).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.